+ Watch SUNH
on My Watchlist
The Company is a nationwide provider, through its subsidiaries, of long-term, sub-acute and related specialty healthcare services principally to the senior population in the United States.
This stock has a very low P/E ratio and solid FCF. Although the annual EPS is a bit overstated due to carryforward losses (that will expire within a year or two), the P/E is still 7-8x annualized earnings.A few other notes:- Revenue, margin, and EPS have grown in line with management projections despite a tough environment.- Ongoing speculation about lower medicaid rates plague this stock, but are greatly overstated.- The only downside is a moderate to heavy debt load. However, most of the debt does not need to be rolled until 2010+. I bought in at 8.40 and see a $14 intrinsic value without paying for any growth. Lots of upside here.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions